Increased inducible nitric oxide synthase and arginase II expression in heart failure: no net nitrite/nitrate production and protein S-nitrosylation.

Our objective was to address the balance of inducible nitric oxide (NO) synthase (iNOS) and arginase and their contribution to contractile dysfunction in heart failure (HF). Excessive NO formation is thought to contribute to contractile dysfunction; in macrophages, increased iNOS expression is associated with increased arginase expression, which competes with iNOS for arginine. With substrate limitation, iNOS may become uncoupled and produce reactive oxygen species (ROS). In rabbits, HF was induced by left ventricular (LV) pacing (400 beats/min) for 3 wk. iNOS mRNA [quantitative real-time PCR (qRT-PCR)] and protein expression (confocal microscopy) were detected, and arginase II expression was quantified with Western blot; serum arginine and myocardial nitrite and nitrate concentrations were determined by chemiluminescence, and protein S-nitrosylation with Western blot. Superoxide anions were quantified with dihydroethidine staining. HF rabbits had increased LV end-diastolic diameter [20.0 + or - 0.5 (SE) vs. 17.2 + or - 0.3 mm in sham] and decreased systolic fractional shortening (11.1 + or - 1.4 vs. 30.6 + or - 0.7% in sham; both P < 0.05). Myocardial iNOS mRNA and protein expression were increased, however, not associated with increased myocardial nitrite or nitrate concentrations or protein S-nitrosylation. The serum arginine concentration was decreased (124.3 + or - 5.6 vs. 155.4 + or - 12.0 micromol/l in sham; P < 0.05) at a time when cardiac arginase II expression was increased (0.06 + or - 0.01 vs. 0.02 + or - 0.01 arbitrary units in sham; P < 0.05). Inhibition of iNOS with 1400W attenuated superoxide anion formation and contractile dysfunction in failing hearts. Concomitant increases in iNOS and arginase expression result in unchanged NO species and protein S-nitrosylation; with substrate limitation, uncoupled iNOS produces superoxide anions and contributes to contractile dysfunction.

[1]  G. Heusch,et al.  Inducible Nitric Oxide Synthase Expression and Cardiomyocyte Dysfunction During Sustained Moderate Ischemia in Pigs , 2008, Circulation research.

[2]  B. Jensen,et al.  Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[3]  A. Shoukas,et al.  Knockdown of Arginase I Restores NO Signaling in the Vasculature of Old Rats , 2006, Hypertension.

[4]  A. Shoukas,et al.  Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Schrader,et al.  Nitric oxide induced contractile dysfunction is related to a reduction in myocardial energy generation. , 1997, Cardiovascular research.

[6]  D. Stewart,et al.  Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. , 2002, The Journal of clinical investigation.

[7]  H. Otani The role of nitric oxide in myocardial repair and remodeling. , 2009, Antioxidants and Redox Signaling.

[8]  G. Heusch,et al.  Serum but not myocardial TNF-alpha concentration is increased in pacing-induced heart failure in rabbits. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  S. Lehnart,et al.  Abnormalities of calcium metabolism and myocardial contractility depression in the failing heart , 2009, Heart Failure Reviews.

[10]  B. Rosengarten,et al.  Effects of inducible nitric oxide synthase inhibition or norepinephrine on the neurovascular coupling in an endotoxic rat shock model , 2009, Critical care.

[11]  M. LeWinter,et al.  Functional Consequences of Sarcomeric Protein Abnormalities in Failing Myocardium , 2005, Heart Failure Reviews.

[12]  Y. Shang,et al.  Nitric oxide signaling in stretch‐induced apoptosis of neonatal rat cardiomyocytes , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  N. Severs,et al.  Connexin45 expression is preferentially associated with the ventricular conduction system in mouse and rat heart. , 1998, Circulation research.

[14]  B. Carabello Aortic stenosis: from pressure overload to heart failure. , 2006, Heart failure clinics.

[15]  J. Sadowski,et al.  Nitric oxide inhibition and the impact on renal nerve‐mediated antinatriuresis and antidiuresis in the anaesthetized rat , 2005, The Journal of physiology.

[16]  R. Erbel,et al.  Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. , 2006, European heart journal.

[17]  Matthew W. Miller,et al.  Upregulation of Vascular Arginase in Hypertension Decreases Nitric Oxide–Mediated Dilation of Coronary Arterioles , 2004, Hypertension.

[18]  O. Binah,et al.  Role of Myocardial Inducible Nitric Oxide Synthase in Contractile Dysfunction and &bgr;-Adrenergic Hyporesponsiveness in Rats With Experimental Volume-Overload Heart Failure , 2002, Circulation.

[19]  Peter P. Liu,et al.  Connecting the missing link between dilated cardiomyopathy and viral myocarditis: virus, cytoskeleton, and innate immunity. , 2006, Circulation.

[20]  P. Ferdinandy,et al.  Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia‐reperfusion injury and preconditioning , 2003, British journal of pharmacology.

[21]  A. Takeshita,et al.  Production of chronic congestive heart failure by rapid ventricular pacing in the rabbit. , 1993, Cardiovascular research.

[22]  D. Bers,et al.  Expression of Inducible Nitric Oxide Synthase Depresses &bgr;-Adrenergic–Stimulated Calcium Release From the Sarcoplasmic Reticulum in Intact Ventricular Myocytes , 2001, Circulation.

[23]  G. Heusch,et al.  Characterization of excitation-contraction coupling in conscious dogs with pacing-induced heart failure. , 1998, Cardiovascular research.

[24]  Increasing post-myocardial infarction heart failure incidence in elderly patients a call for action. , 2009, Journal of the American College of Cardiology.

[25]  P. D. de Tombe,et al.  Integration of Cardiac Myofilament Activity and Regulation with Pathways Signaling Hypertrophy and Failure , 2000, Annals of Biomedical Engineering.

[26]  L. Ignarro,et al.  Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. , 1995, Biochemical and biophysical research communications.

[27]  R. Erbel,et al.  Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. , 2009, Deutsches Arzteblatt international.

[28]  Albert Hofman,et al.  Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. , 2004, European heart journal.

[29]  M. Eigen,et al.  Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Kelm,et al.  Endogenous nitric oxide and myocardial adaptation to ischemia. , 2000, Circulation research.

[31]  A. Holian,et al.  Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. , 2007, American journal of respiratory cell and molecular biology.

[32]  U. Flögel,et al.  Cardiac-Specific Overexpression of Inducible Nitric Oxide Synthase Does Not Result in Severe Cardiac Dysfunction , 2002, Circulation research.

[33]  J. V. Van Eyk,et al.  Evidence of myofibrillar protein oxidation induced by postischemic reperfusion in isolated rat hearts. , 2004, American journal of physiology. Heart and circulatory physiology.

[34]  N. Bryan,et al.  Cellular targets and mechanisms of nitros(yl)ation: An insight into their nature and kinetics in vivo , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Bache,et al.  Nitric Oxide Modulates Myocardial Oxygen Consumption in the Failing Heart , 2002, Circulation.

[36]  G. Heusch,et al.  Myocardial, skeletal muscle, and renal blood flow during exercise in conscious dogs with heart failure. , 1997, American journal of physiology. Heart and circulatory physiology.

[37]  T. Rassaf,et al.  Reductive gas-phase chemiluminescence and flow injection analysis for measurement of the nitric oxide pool in biological matrices. , 2008, Methods in enzymology.

[38]  G. Heusch,et al.  No involvement of nitric oxide in the limitation of beta-adrenergic inotropic responsiveness during ischemia. , 2001, American journal of physiology. Heart and circulatory physiology.

[39]  S. Hussain,et al.  Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure: their relation to lesion site and beta-adrenergic receptor therapy. , 1998, Circulation.

[40]  J. Balligand,et al.  Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. , 2005, Pharmacology & therapeutics.

[41]  P. Armstrong,et al.  Pacing-induced heart failure: a model to study the mechanism of disease progression and novel therapy in heart failure. , 1999, Cardiovascular research.

[42]  A. Takeshita,et al.  Disruption of Inducible Nitric Oxide Synthase Improves &bgr;-Adrenergic Inotropic Responsiveness but Not the Survival of Mice With Cytokine-Induced Cardiomyopathy , 2002, Circulation research.

[43]  J. Murabito,et al.  Lifetime Risk for Developing Congestive Heart Failure: The Framingham Heart Study , 2002, Circulation.

[44]  N. Westerhof,et al.  Nitric oxide and cardiac function. , 2007, Life sciences.

[45]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[46]  Q. Feng,et al.  Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure. , 2005, Pharmacology & therapeutics.

[47]  Miriam V. Liscovsky,et al.  Interferon‐γ priming is involved in the activation of arginase by oligodeoxinucleotides containing CpG motifs in murine macrophages , 2009, Immunology.

[48]  Xinli Hu,et al.  Inducible Nitric Oxide Synthase Deficiency Protects the Heart From Systolic Overload–Induced Ventricular Hypertrophy and Congestive Heart Failure , 2007, Circulation research.

[49]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.

[50]  G. Heusch,et al.  Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits. , 2004, Cardiovascular research.

[51]  W. Little Hypertension, heart failure, and ejection fraction. , 2008, Circulation.

[52]  S. Moncada,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1997, Circulation.

[53]  V. Richard,et al.  NO produced by endothelial NO synthase is a mediator of delayed preconditioning-induced endothelial protection. , 2003, American journal of physiology. Heart and circulatory physiology.

[54]  M. Duchen,et al.  Effects of NO on mitochondrial function in cardiomyocytes: Pathophysiological relevance. , 2006, Cardiovascular research.

[55]  R. Bolli,et al.  Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and delta1-opioid receptor agonists is mediated by iNOS. , 2005, American journal of physiology. Heart and circulatory physiology.

[56]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[57]  D. Harrison,et al.  Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. , 1998, Journal of molecular and cellular cardiology.

[58]  Péter Ferdinandy,et al.  Peroxynitrite: just an oxidative/nitrosative stressor or a physiological regulator as well? , 2006, British journal of pharmacology.

[59]  G. Supic,et al.  Increased nitric oxide formation followed by increased arginase activity induces relative lack of arginine at the wound site and alters whole nutritional status in rats almost within the early healing period. , 2009, Nitric oxide : biology and chemistry.

[60]  Paul Tempst,et al.  Protein S-nitrosylation: a physiological signal for neuronal nitric oxide , 2001, Nature Cell Biology.

[61]  UlrichFlögel,et al.  Acute Inhibition of Myoglobin Impairs Contractility and Energy State of iNOS-Overexpressing Hearts , 2003 .

[62]  W. Seeger,et al.  Effect of nitric oxide synthase (NOS) inhibition on macro- and microcirculation in a model of rat endotoxic shock , 2006, Thrombosis and Haemostasis.

[63]  G. Heusch,et al.  Stress kinase phosphorylation is increased in pacing-induced heart failure in rabbits. , 2003, American journal of physiology. Heart and circulatory physiology.

[64]  Richard Graham Knowles,et al.  1400W Is a Slow, Tight Binding, and Highly Selective Inhibitor of Inducible Nitric-oxide Synthase in Vitro and in Vivo* , 1997, The Journal of Biological Chemistry.

[65]  G. Heusch,et al.  Calcium responsiveness in canine pacing-induced heart failure. , 1998, Journal of Molecular and Cellular Cardiology.

[66]  P. Tsao,et al.  Expression of inducible nitric oxide synthase in human heart failure. , 1996, Circulation.

[67]  D. Malan,et al.  Regulation of cardiac calcium current by NO and cGMP-modulating agents , 2001, Pflügers Archiv.